Yuanbao (NASDAQ:YB) Shares Down 0.4% - Time to Sell?

Key Points

• Yuanbao's shares declined by 0.4% during mid-day trading, with the stock last trading at $25.16.
• Wall Street Zen downgraded Yuanbao from a "buy" rating to a "hold" rating on June 15th.
• The company reported $0.89 earnings per share and $133.68 million in revenue for the last quarter ending June 5th.

Yuanbao Inc. - Sponsored ADR (NASDAQ:YB - Get Free Report)'s share price was down 0.4% during mid-day trading on Thursday . The company traded as low as $25.16 and last traded at $25.16. Approximately 50,599 shares traded hands during trading, an increase of 9% from the average daily volume of 46,264 shares. The stock had previously closed at $25.27.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut Yuanbao from a "buy" rating to a "hold" rating in a research report on Sunday, June 15th.

Yuanbao Stock Down 0.4%

The business has a fifty day moving average price of $25.14.

Yuanbao (NASDAQ:YB - Get Free Report) last issued its earnings results on Thursday, June 5th. The company reported $0.89 earnings per share (EPS) for the quarter. The company had revenue of $133.68 million for the quarter.

Hedge Funds Weigh In On Yuanbao

Several institutional investors have recently modified their holdings of YB. Federated Hermes Inc. bought a new position in shares of Yuanbao during the 2nd quarter valued at about $370,000. JPMorgan Chase & Co. bought a new position in shares of Yuanbao during the 2nd quarter valued at about $454,000. Finally, WFM ASIA BVI Ltd bought a new position in shares of Yuanbao during the 2nd quarter valued at about $2,020,000.

About Yuanbao

Our mission is to protect health and well-being through technology. We are a leading technology-driven online insurance distributor in China. We take pride in pioneering the seamless integration of insurance with cutting-edge technologies, and have constructed a highly efficient full consumer service cycle engine.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.